Table 3.
RP pseudogenes expression identified in Human Body Map 2.0 RNA-seq data
| pg-id | Parent gene | Location | Tissue with Max RPKM | Max RPKM | Total RPKM | Tissue specificity | Reads coverage |
|---|---|---|---|---|---|---|---|
| 249508 |
RPL21 |
chr8:134084035-134084502 |
Thyroid |
170.3 |
170.6 |
0.977 |
0.976 |
| 237215 |
RPL7A |
chr17:6984988-6985635 |
White Blood Cells |
17.3 |
18.0 |
0.881 |
0.913 |
| 249146 |
RPS24 |
chr16:55497947-55498335 |
Kidney |
16.5 |
17.6 |
0.855 |
0.693 |
| 239833 |
RPS11 |
chr12:63076580-63077044 |
Testes |
11.3 |
12.5 |
0.813 |
0.970 |
| 236635 |
RPL24 |
chr9:72021934-72022269 |
Colon |
9.7 |
9.7 |
1.000 |
0.358 |
| 248697 |
RPL26 |
chr16:1953719-1954097 |
Lymph |
9.0 |
37.9 |
0.376 |
0.854 |
| 242376 |
RPS20 |
chr11:77202016-77202370 |
Colon |
8.6 |
41.6 |
0.355 |
1.00 |
| 251340 |
RPLP1 |
chr5:151125656-151125993 |
Testes |
7.4 |
40.1 |
0.339 |
0.567 |
| 237777 |
RPL7 |
chr3:133445060-133445787 |
Prostate |
7.3 |
8.0 |
0.819 |
0.371 |
| 234492 |
RPL10 |
chr19:9791817-9792131 |
Brain |
7.2 |
10.8 |
0.635 |
0.121 |
| 248932 |
RPL21 |
chr16:72904438-72904782 |
Ovary |
6.5 |
34.3 |
0.343 |
1.00 |
| 234407 |
RPL39 |
chr19:58143205-58143330 |
Colon |
6.3 |
21.3 |
0.414 |
1.00 |
| 239633 |
RPL13 |
chr12:6863424-6864038 |
Kidney |
6.0 |
27.0 |
0.365 |
0.923 |
| 245936 |
RPL6 |
chr4:66121772-66122638 |
Colon |
5.9 |
7.2 |
0.746 |
0.109 |
| 243590 |
RPL32 |
chr6:33155206-33155612 |
Adrenal |
5.8 |
9.2 |
0.617 |
1.00 |
| 241074 |
RPL13A |
chr2:203093361-203093957 |
Lung |
5.4 |
9.7 |
0.571 |
0.995 |
| 238877 | RPL11 | chr10:89695235-89695766 | Adipose | 5.2 | 20.4 | 0.387 | 0.847 |
Expression levels of pseudogenes with their pseudogene ID (pg-id, prefix ‘PGOHUM00000’ omitted) are measured in terms of RPKM. Only pseudogenes with maximum RPKM > 5 are shown. Tissue specificities are measured by the JS divergence [20]. Read coverage is the ratio of pseudogene exon length covered by uniquely mapped reads to the total pseudogene exon length.